|Disease area and portfolio strategies|
|We develop options for clinical development and commercialisation within different disease areas and across product portfolios including:|
|Prioritisation based on market attractiveness, competitive position and capabilities.|
|Transparent criteria and evaluation assumptions to define priorities.|
|Trade-off of revenue opportunity vs. development and commercial potential to define and prioritise disease or market opportunities.|
|We analyse existing processes, identifying and adapting to opportunities to meet new organisational goals.
|Alignment of research, development and commercial opportunities to deliver coherent strategy.|
|Clearly defined decision-making recommendations to improve process flow.|
|Benchmarking of competitors to help define 'best practice'.|
|Plans are nothing. Planning is everything."
Dwight D. Eisenhower
|Copyright © Fletcher Associates GmbH ¦ All rights reserved|